Docetaxel With or Without Bintrafusp Alfa for the Treatment of Advanced Non-small Cell Lung Cancer
Phase 2 Terminated
10 enrolled 17 charts
Pembro+Chemo in Brain Mets
Phase 2 Terminated
3 enrolled 7 charts
PAVO
Phase 2 Terminated
22 enrolled 17 charts
PROACT
Phase 2 Terminated
49 enrolled 12 charts
A Study of EGF816 and Gefitinib in TKI-naïve EGFR-mutant Non-Small Cell Lung Cancer
Phase 2 Terminated
11 enrolled 10 charts
Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer
Phase 2 Terminated
1 enrolled
Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer
Phase 2 Terminated
265 enrolled 8 charts
Induction Chemo-Nivo in Unresectable Stage III NSCLC
Phase 2 Terminated
1 enrolled
A Study of Sapanisertib in Relapsed/Refractory NFE2L2-Mutated and Wild-Type Squamous Non-Small Cell Lung Cancer
Phase 2 Terminated
7 enrolled 11 charts
A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)
Phase 2 Terminated
1 enrolled 4 charts
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
Phase 2 Terminated
54 enrolled 11 charts
Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients
Phase 2 Terminated
4 enrolled 9 charts
LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Phase 2 Terminated
6 enrolled 14 charts
A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF)
Phase 2 Terminated
61 enrolled 26 charts
LODESTAR
Phase 2 Terminated
83 enrolled 16 charts
ENSIGN
Phase 2 Terminated
11 enrolled 9 charts
Subsequent Line Gemcitabine and Nivolumab in Treating Participants With Metastatic Small Cell Lung Cancer
Phase 2 Terminated
14 enrolled 14 charts
Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung Cancer
Phase 2 Terminated
3 enrolled 8 charts
A Phase 2 Exploratory Study of Erlotinib and SNDX-275 in Participants With Non-small Cell Lung Carcinoma Who Are Progressing on Erlotinib
Phase 2 Terminated
8 enrolled 6 charts
ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy
Phase 2 Terminated
1 enrolled 10 charts
FIND
Phase 2 Terminated
22 enrolled
PRESERVE 4
Phase 2 Terminated
10 enrolled 14 charts
Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC)
Phase 2 Terminated
14 enrolled 12 charts
Pembrolizumab vs Topotecan in Patients With Small Cell Lung Cancer
Phase 2 Terminated
9 enrolled 11 charts
Brigatinib Before Brain Irradiation Trial (B3i Trial)
Phase 2 Terminated
1 enrolled 6 charts
Bintrafusp Alfa Before Surgery for the Treatment of Untreated Resectable Non-small Cell Lung Cancer
Phase 2 Terminated
2 enrolled 7 charts
Single Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary Resistance to Prior PD-1 or PDL-1 Inhibitor
Phase 2 Terminated
3 enrolled 11 charts
Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer
Phase 2 Terminated
5 enrolled 6 charts
Dietary Flaxseed in NSCLC
Phase 2 Terminated
33 enrolled
Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase 2 Terminated
39 enrolled 9 charts
IRENE
Phase 2 Terminated
21 enrolled
A Study of SHR-1210 in Combination With BP102 in Subjects With Non-squamous NSCLC
Phase 2 Terminated
5 enrolled
Trial of Cabozantinib (XL184) in Non-Small Cell Lung Cancer With Brain Metastases
Phase 2 Terminated
5 enrolled 18 charts
Phase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the Lung
Phase 2 Terminated
162 enrolled
Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura
Phase 2 Terminated
9 enrolled 5 charts
Stereotactic Body Radiotherapy (SBRT) Versus Sublobar Resection for High-Risk Patients Non-Small Lung Cancer
Phase 2 Terminated
20 enrolled
Oral Navelbine and Cisplatin Followed by Metronomic Oral Navelbine in Non-Small Cell Lung Cancer
Phase 2 Terminated
45 enrolled
Cannabis Oil and Radiation Therapy for the Management of Pain
Phase 2 Terminated
100 enrolled
Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer
Phase 2 Terminated
6 enrolled 5 charts
Advanced Non-Small Cell Lung Cancer Progressing After at Least One Prior Therapy For Metastatic Disease
Phase 2 Terminated
10 enrolled 8 charts
Metformin in Non Small Cell Lung Cancer (NSCLC)
Phase 2 Terminated
27 enrolled 11 charts
Mithramycin for Lung, Esophagus, and Other Chest Cancers
Phase 2 Terminated
16 enrolled 13 charts
Treating NSCLC Minimal Stage IV With Curative Intent
Phase 2 Terminated
14 enrolled
Cisplatin/Irinotecan With Concurrent Radiation for Inoperable NSCLC
Phase 2 Terminated
4 enrolled
A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations
Phase 2 Terminated
18 enrolled
An Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations
Phase 2 Terminated
59 enrolled 9 charts
Anti-Mesothelin Antibody Drug Conjugate Anetumab Ravtansine for Mesothelin Expressing Lung Adenocarcinoma
Phase 2 Terminated
2 enrolled 12 charts
The ATTAIN Study: A Therapeutic Trial of Afatinib In the Neoadjuvant Setting
Phase 2 Terminated
2 enrolled 8 charts
Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by Surgery
Phase 2 Terminated
2 enrolled 4 charts
Sorafenib in Treating Non-Smokers or Former Light Smokers With Relapsed or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase 2 Terminated
11 enrolled 8 charts